Related Experiment Videos
Insulin resistance--the new goal!
P Peter1, S L Nuttall, M J Kendall
1Clinical Investigations Unit, Division of Medical Sciences, Queen Elizabeth Hospital, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Journal of Clinical Pharmacy and Therapeutics
|June 11, 2003
Summary
Diabetes significantly increases coronary artery disease (CAD) risk, with rising prevalence and mortality. Addressing insulin resistance (IR) is a key focus for managing cardiovascular complications in diabetic patients.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Diabetes mellitus is a major risk factor for coronary artery disease (CAD), increasing risk two to sixfold.
- The global prevalence of diabetes is rising, with a 30% increase in the UK since 1991.
- CAD mortality has declined in non-diabetics but remains unchanged or increased in diabetic men and women, respectively.
Purpose of the Study:
- To review the concept of insulin resistance (IR) in the context of cardiovascular disease.
- To explore potential interventions for managing IR and its associated cardiovascular risks.
- To highlight the challenges in improving macrovascular outcomes in diabetic patients despite good glycemic control.
Main Methods:
- Review of epidemiological studies on diabetes and CAD risk.
- Analysis of trends in CAD mortality in diabetic versus non-diabetic populations.
- Examination of the role of insulin resistance (IR) and associated abnormalities in cardiovascular disease development.
Main Results:
- Good diabetic control improves microvascular complications but not macrovascular ones.
- Insulin resistance (IR) is linked to abnormalities that may cause cardiovascular disease.
- Current approaches include tighter glycemic control, hypertension management, and targeting the prediabetic state.
Conclusions:
- Improved diabetic control does not guarantee better macrovascular outcomes.
- Insulin resistance (IR) presents a critical area for intervention in cardiovascular disease prevention.
- Further research and novel strategies are needed to address the cardiovascular burden in diabetes.